Two EMBEDA video news releases misleading, warns FDA DDMAC (News-Medical-Net)

More info…
On October 8, 2009, King Pharmaceuticals, Inc. received a Warning Letter from the Division of Drug Marketing, Advertising, and Communications (DDMAC) at the Food and Drug Administration regarding two video news releases – EMBEDA Media backgrounder, and EMBEDA Visual Media Technology, for EMBEDA (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules for oral use C-II.

naltrexone drug